deoxycytidine and Thrombocythemia, Essential

deoxycytidine has been researched along with Thrombocythemia, Essential in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gauthier, M; Laurent, C; Mouchel, PL; Syrykh, C; Tavitian, S1

Other Studies

1 other study(ies) available for deoxycytidine and Thrombocythemia, Essential

ArticleYear
First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy.
    American journal of hematology, 2021, 06-01, Volume: 96, Issue:6

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Humans; Immunocompromised Host; Lymph Nodes; Lymphoproliferative Disorders; Male; Middle Aged; Nitriles; PAX5 Transcription Factor; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reed-Sternberg Cells; RNA, Viral; Thrombocythemia, Essential; Vinblastine

2021